vs
Alarm.com Holdings, Inc.（ALRM）与Apellis Pharmaceuticals, Inc.（APLS）财务数据对比。点击上方公司名可切换其他公司
Alarm.com Holdings, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.3倍（$261.7M vs $199.9M），Alarm.com Holdings, Inc.净利率更高（13.2% vs -29.5%，领先42.7%），Alarm.com Holdings, Inc.同比增速更快（8.0% vs -5.9%），Alarm.com Holdings, Inc.自由现金流更多（$35.1M vs $-14.3M），过去两年Alarm.com Holdings, Inc.的营收复合增速更高（8.3% vs 7.7%）
Alarm.com Holdings, Inc.是一家美国科技企业，成立于2000年，由微策略公司分拆而来，总部位于弗吉尼亚州泰森斯。公司主营云服务，为用户提供远程控制、智能家居及报警监测相关解决方案，是家庭智能安防领域的重要服务商。
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
ALRM vs APLS — 直观对比
营收规模更大
ALRM
是对方的1.3倍
$199.9M
营收增速更快
ALRM
高出14.0%
-5.9%
净利率更高
ALRM
高出42.7%
-29.5%
自由现金流更多
ALRM
多$49.4M
$-14.3M
两年增速更快
ALRM
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.7M | $199.9M |
| 净利润 | $34.6M | $-59.0M |
| 毛利率 | 66.0% | — |
| 营业利润率 | 13.4% | -25.6% |
| 净利率 | 13.2% | -29.5% |
| 营收同比 | 8.0% | -5.9% |
| 净利润同比 | 14.8% | -62.2% |
| 每股收益（稀释后） | $0.66 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALRMAPLS
| Q4 25 | $261.7M | $199.9M | ||
| Q3 25 | $256.4M | $458.6M | ||
| Q2 25 | $254.3M | $178.5M | ||
| Q1 25 | $238.8M | $166.8M | ||
| Q4 24 | $242.2M | $212.5M | ||
| Q3 24 | $240.5M | $196.8M | ||
| Q2 24 | $233.8M | $199.7M | ||
| Q1 24 | $223.3M | $172.3M |
净利润ALRMAPLS
| Q4 25 | $34.6M | $-59.0M | ||
| Q3 25 | $35.1M | $215.7M | ||
| Q2 25 | $34.2M | $-42.2M | ||
| Q1 25 | $27.7M | $-92.2M | ||
| Q4 24 | $30.1M | $-36.4M | ||
| Q3 24 | $36.7M | $-57.4M | ||
| Q2 24 | $33.5M | $-37.7M | ||
| Q1 24 | $23.6M | $-66.4M |
毛利率ALRMAPLS
| Q4 25 | 66.0% | — | ||
| Q3 25 | 65.8% | — | ||
| Q2 25 | 65.6% | — | ||
| Q1 25 | 67.2% | — | ||
| Q4 24 | 65.5% | — | ||
| Q3 24 | 64.8% | — | ||
| Q2 24 | 65.2% | — | ||
| Q1 24 | 65.7% | — |
营业利润率ALRMAPLS
| Q4 25 | 13.4% | -25.6% | ||
| Q3 25 | 14.4% | 48.7% | ||
| Q2 25 | 12.6% | -18.6% | ||
| Q1 25 | 12.4% | -50.0% | ||
| Q4 24 | 12.7% | -12.3% | ||
| Q3 24 | 13.8% | -24.0% | ||
| Q2 24 | 11.0% | -14.7% | ||
| Q1 24 | 8.4% | -36.0% |
净利率ALRMAPLS
| Q4 25 | 13.2% | -29.5% | ||
| Q3 25 | 13.7% | 47.0% | ||
| Q2 25 | 13.5% | -23.6% | ||
| Q1 25 | 11.6% | -55.3% | ||
| Q4 24 | 12.4% | -17.1% | ||
| Q3 24 | 15.3% | -29.2% | ||
| Q2 24 | 14.3% | -18.9% | ||
| Q1 24 | 10.6% | -38.5% |
每股收益（稀释后）ALRMAPLS
| Q4 25 | $0.66 | $-0.40 | ||
| Q3 25 | $0.65 | $1.67 | ||
| Q2 25 | $0.63 | $-0.33 | ||
| Q1 25 | $0.52 | $-0.74 | ||
| Q4 24 | $0.56 | $-0.30 | ||
| Q3 24 | $0.67 | $-0.46 | ||
| Q2 24 | $0.62 | $-0.30 | ||
| Q1 24 | $0.44 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $960.6M | $466.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $848.2M | $370.1M |
| 总资产 | $2.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALRMAPLS
| Q4 25 | $960.6M | $466.2M | ||
| Q3 25 | $1.1B | $479.2M | ||
| Q2 25 | $1.0B | $370.0M | ||
| Q1 25 | $1.2B | $358.4M | ||
| Q4 24 | $1.2B | $411.3M | ||
| Q3 24 | $1.2B | $396.9M | ||
| Q2 24 | $1.1B | $360.1M | ||
| Q1 24 | $747.9M | $325.9M |
总债务ALRMAPLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $93.1M |
股东权益ALRMAPLS
| Q4 25 | $848.2M | $370.1M | ||
| Q3 25 | $827.2M | $401.2M | ||
| Q2 25 | $797.3M | $156.3M | ||
| Q1 25 | $759.6M | $164.2M | ||
| Q4 24 | $726.5M | $228.5M | ||
| Q3 24 | $690.3M | $237.1M | ||
| Q2 24 | $645.5M | $264.3M | ||
| Q1 24 | $728.1M | $266.7M |
总资产ALRMAPLS
| Q4 25 | $2.1B | $1.1B | ||
| Q3 25 | $2.1B | $1.1B | ||
| Q2 25 | $2.1B | $821.4M | ||
| Q1 25 | $2.1B | $807.3M | ||
| Q4 24 | $2.0B | $885.1M | ||
| Q3 24 | $2.0B | $901.9M | ||
| Q2 24 | $1.9B | $904.5M | ||
| Q1 24 | $1.5B | $831.9M |
负债/权益比ALRMAPLS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.9M | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $35.1M | $-14.3M |
| 自由现金流率自由现金流/营收 | 13.4% | -7.1% |
| 资本支出强度资本支出/营收 | 0.3% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $137.0M | $45.0M |
8季度趋势，按日历期对齐
经营现金流ALRMAPLS
| Q4 25 | $35.9M | $-14.2M | ||
| Q3 25 | $70.6M | $108.5M | ||
| Q2 25 | $22.7M | $4.4M | ||
| Q1 25 | $24.1M | $-53.4M | ||
| Q4 24 | $56.3M | $19.4M | ||
| Q3 24 | $77.3M | $34.1M | ||
| Q2 24 | $23.0M | $-8.3M | ||
| Q1 24 | $49.9M | $-133.0M |
自由现金流ALRMAPLS
| Q4 25 | $35.1M | $-14.3M | ||
| Q3 25 | $65.9M | $108.3M | ||
| Q2 25 | $18.2M | $4.4M | ||
| Q1 25 | $17.9M | $-53.4M | ||
| Q4 24 | $54.0M | $19.3M | ||
| Q3 24 | $74.5M | — | ||
| Q2 24 | $21.0M | $-8.4M | ||
| Q1 24 | $46.8M | $-133.3M |
自由现金流率ALRMAPLS
| Q4 25 | 13.4% | -7.1% | ||
| Q3 25 | 25.7% | 23.6% | ||
| Q2 25 | 7.1% | 2.5% | ||
| Q1 25 | 7.5% | -32.0% | ||
| Q4 24 | 22.3% | 9.1% | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 9.0% | -4.2% | ||
| Q1 24 | 21.0% | -77.3% |
资本支出强度ALRMAPLS
| Q4 25 | 0.3% | 0.1% | ||
| Q3 25 | 1.9% | 0.0% | ||
| Q2 25 | 1.8% | 0.0% | ||
| Q1 25 | 2.6% | 0.0% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 1.4% | 0.2% |
现金转化率ALRMAPLS
| Q4 25 | 1.04× | — | ||
| Q3 25 | 2.01× | 0.50× | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.87× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.69× | — | ||
| Q1 24 | 2.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALRM
| License And Service | $180.2M | 69% |
| Hardwareand Other Revenue | $81.4M | 31% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
